Founded in Rockville, Maryland, in January 2025, BioArk Technologies is a young biotechnology company led by founder and CEO Dr. Lipeng Wu alongside physician-scientist and co-founder Dr. Jingwen Xu. The company is known for translating genome-engineering research into practical support for academic, biotechnology, and pharmaceutical researchers, with its CRISPR Trinity Platform serving as a distinctive focus.